MentionFox
Home › funding signals › Sixfold Bioscience
Accelerator · announced

Sixfold Bioscience (YC W18) — Delivering RNA therapies

Sixfold Bioscience appears in Y Combinator's company directory in the Winter 2018 batch, listed 2017-11-01. Delivering RNA therapies..

Just raised? Share it.

Sixfold Bioscience: Accepted into Y Combinator Winter 2018

What do you want to do with Sixfold Bioscience?

Sixfold Bioscience

New accelerator entry · 2017-11-01 · the record

Winter 2018
batch
27
people
Early
stage
United Kingdom
region
Open the record →

In their words

Sixfold is focused on the commercialisation of its patented drug delivery systems for RNA therapeutics such as siRNAs for gene silencing and mRNAs for gene expression.

What the record says

BatchWinter 2018
Announced2017-11-01
StageEarly
StatusActive
Team size27
IndustryHealthcare
Sub-industryHealthcare -> Drug Discovery and Delivery
SectorsGene Therapy, Nanomedicine, Drug Delivery
RegionsUnited Kingdom, Europe
BasedLondon, England, United Kingdom
HiringNo
Sitehttps://www.sixfold.bio
Previously known asSixfold Bioscience

The full profile

Checking your access…

Is this you?

If you're behind Sixfold Bioscience: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

Tools for this story

Each opens in a new tab, filled in for Sixfold Bioscience. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-sixfold-bioscience
Last updated 2026-09-26
Primary record: Y Combinator directory entry
Sixfold Bioscience (YC W18) — Delivering RNA therapies. MentionFox, 2026-09-26. https://mentionfox.com/funding/yc-sixfold-bioscience